mites

A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK-Abello A/S, Originator or ALK HDM Tablets in Adult Subjects With Allergic Rhinitis and/or Atopic Asthma Induced by House Dust Mites (HDM)

Conditions:   Allergy;   Asthma;   RhinitisInterventions:   Drug: Mitizax;   Drug: PlaceboSponsors:   Abbott;   Linical Co., Ltd;   DatamapRecruiting – verified November 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK-Abello A/S, Originator or ALK HDM Tablets (ALK HDM Tablets) in Adult Subjects With Allergic Rhinitis and/or Atopic Asthma Induced by House Dust Mites (HDM)

Conditions:   Allergy;   Asthma;   RhinitisInterventions:   Drug: Mitizax;   Drug: PlaceboSponsors:   Abbott;   Linical Co., Ltd;   DatamapRecruiting – verified November 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma

Conditions:   Rhinitis;   Rhinoconjunctivitis;   AsthmaInterventions:   Biological: DP/MG/14-1;   Biological: DP/MG/14-2Sponsor:   Laboratorios Leti, S.L.Recruiting – verified January 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days